fatnews.com Home page  >  Article | Previous article | Next article



  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Follow @fatnews

    Clinical investigators may contribute little of essence to drug trials or guidelines, John Ioannidis

    Posted by .(JavaScript must be enabled to view this email address)
    Wednesday, December 14, 2016 9:05 am Email this article

    “Clinical investigators flock to try to get coauthorship in multicenter trials, meta-analyses, and powerful guidelines to which they contribute little of essence,” notes John Ioannidis from Stanford University.

    Ioannidis continues by saying,

    “Vested interests dictate preemptively large segments of the research agenda and its evidence-based aura which is further propagated in professional societies and large conferences.

    “Many leaders and members of powerful professional societies and academies and other august bodies grow out of this system.

    “It is sometimes difficult to tell whether a superb CV with a lengthy publication list reflects hard work and brilliant leadership or the composite product of dexterous power game networking, gift authorship, and excellence in the slave trade of younger researchers.”


    Ioannidis JP. Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epidemiol, 2016 Mar 2; http://www.jclinepi.com/article/S0895-4356(16)00147-5/fulltext.

    Author’s Contact Info

    John Ioannidis
    Department of Medicine
    Department of Statistics
    Stanford University
    1265 Welch Rd, MSOB X306
    Stanford, CA 94305, USA
    Tel.: 650-7236147
    .(JavaScript must be enabled to view this email address)

    Articles on the same subject can be found here:


    Please feel free to share your comments about this article.




    Please enter the word you see in the image below:

    Remember my personal information

    Notify me of follow-up comments?

    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.